Challenges of Iranian clinicians in dealing with COVID-19: Taking advantages of the experiences in Wenzhou

Li, Y. and Tahamtani, Y. and Totonchi, M. and Chen, C. and Hashemian, S.M.R. and Amoozegar, F. and Zhang, J.-S. and Gholampour, Y. and Li, X. (2020) Challenges of Iranian clinicians in dealing with COVID-19: Taking advantages of the experiences in Wenzhou. Cell Journal.

Full text not available from this repository.
Official URL: https://www.scopus.com/inward/record.uri?eid=2-s2....

Abstract

The novel coronavirus has been spreading since December 2019. It was initially reported in Wuhan, Hubei province of China. Coronavirus disease 2019 (COVID-19) has currently become a pandemic affecting over seven million people worldwide, and the number is still rising. Wenzhou, as the first hit city out of Hubei Province, achieved a remarkable success in effectively containing the disease. A great record was also observed in Wenzhou for the clinical management of COVID-19 patients, leading to one of the lowest death rates in China. Researchers and clinical specialists proposed and formulated combined approaches such as computerized tomography (CT)- scans and molecular assays, as well as using both allopathic and traditional medications to mitigate its effects. Iranian and Chinese specialists and scientists had a communication in clinical, molecular and pharmaceutical aspects of COVID-19. A proper guideline was prepared according to the experiences of Chinese clinicians in managing the full spectrum of COVID-19 patients, from relatively mild to highly complex cases. The purpose of this guideline is to serve a reference in the hospital for specialists so that they may better diagnose cases and provide effective therapies and proposed antiviral and anti-inflammatory drugs for patients. © 2020 Royan Institute (ACECR). All rights reserved.

Item Type: Article
Depositing User: Unnamed user with email eprints@fums.ac.ir
Date Deposited: 07 Nov 2020 06:25
Last Modified: 07 Nov 2020 06:26
URI: http://eprints.fums.ac.ir/id/eprint/2766

Actions (login required)

View Item View Item